icaritin,
Icaritin,
118525-40-9,
UNII-UFE666UELY,
UFE666UELY,
CHEMBL498485,
3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one,
3,5,7-Trihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-4H-1-benzopyran-4-one,
Cycloicaritin,
Icartin,
Anhydroicaritin;,
AC1NSXIV,
Icaritin(Anhydroicaritin),
MLS006010055,
BIDD:ER0021,
SCHEMBL4223542,
Icaritin, >=98% (HPLC),
DTXSID00152154,
TUUXBSASAQJECY-UHFFFAOYSA-N,
HY-N0678,
BDBM50272527,
MFCD22422519,
ZINC14762797,
AKOS015896858,
CS-3679,
DB12672,
NCGC00345813-01,
4CN-1168,
AK168251,
SMR004701218,
FT-0670266,
I0974,
Y0107,
I07-0147,
3-hydroxy-7-o-beta-glucose-8-prenyl-4''-methoxy Chrysin,
3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-4H-chromen-4-one,
4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-,
4H-1-Benzopyran-4-one,3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-,
Anhydroicaritin,
Anhydroicaritin Li,
D0L0BX,
C21H20O6,
ACN-035743,
CID5318980,
C499403,
4H-1-benzopyran-4-one, 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-,